Related Experiment Video
Updated: Feb 3, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Evaluation of cardiac function by global longitudinal strain before and after treatment with sofosbuvir-based
Maria Mazzitelli1, Carlo Torti2, Jolanda Sabatino3
1Unit of Infectious and Tropical Diseases, Department of Medical and Surgical Sciences, "Magna Graecia" University of Catanzaro, Viale Europa, 88100, Catanzaro, Italy.
Insights
Hepatitis C treatment with sofosbuvir-based regimens may worsen heart function, as measured by global longitudinal strain (GLS). Further research is needed to confirm clinical significance and the safety of these direct-acting antiviral (DAA) treatments.
Area of Science:
- Cardiology
- Hepatology
- Pharmacology
Background:
- Hepatitis C virus (HCV) infection can negatively impact cardiac function.
- The potential cardiotoxicity of sofosbuvir, a direct-acting antiviral (DAA), remains unconfirmed in humans.
- Assessing left ventricular function using global longitudinal strain (GLS) offers greater sensitivity than ejection fraction (EF).
Purpose of the Study:
- To evaluate the impact of HCV treatment with DAAs, including sofosbuvir, on left ventricular function.
- To determine if HCV eradication confers cardiac benefits using GLS.
- To investigate potential cardiotoxicity associated with sofosbuvir-based therapies.
Main Methods:
- Prospective study involving 82 patients undergoing HCV treatment with DAAs.
- Transthoracic cardiac ultrasound performed at four time points: baseline, 1 month, end of treatment, and 6 months post-treatment.
- Left ventricular function assessed using both ejection fraction (EF) and global longitudinal strain (GLS).
Main Results:
- A statistically significant worsening trend in global longitudinal strain (GLS) was observed post-HCV treatment.
- No significant variations were found in ejection fraction (EF) during the follow-up period.
- The decline in GLS remained statistically significant after adjusting for body mass index and liver fibrosis, irrespective of treatment duration.
Conclusions:
- HCV treatment with direct-acting antivirals, including sofosbuvir, was unexpectedly associated with a worsening of left ventricular function as measured by GLS.
- While the observed GLS changes were statistically significant, their clinical significance requires further investigation.
- The safety profile of sofosbuvir-based regimens warrants continued and thorough study.
Background:
Possible cardiotoxicity of sofosbuvir in humans has not been demonstrated yet. Also, since HCV can exert deleterious effects on hearth function, it is of interest to know whether HCV eradication provides any benefits using global longitudinal strain (GLS), a measure of left ventricular function more reliable than ejection fraction (EF).
Methods:
Patients eligible for treatment with the combination therapy for HCV were invited to perform a transthoracic cardiac ultrasound at four different time points: before starting treatment, after one month, at the end of treatment and, after six month. Left ventricular function was measured with both EF and GLS.
Results:
From March 2015 to December 2016, 82 patients were enrolled. Fifty-six percent patients were males. Mean age was 66.12 (SD: 9.25) years. About 20% patients did not present any cardiovascular risk factors or comorbidities. A worsening trend of GLS was observed. Variations were not found to be statistically significant when EF was studied along the follow-up. However, when GLS was studied, its variations were found to be statistically significant indicating a worsening effect, albeit with different trends in patients who underwent treatment for three months compared to six months. Worsening of GLS was found to be statistically significant even after adjusting for body mass index and liver fibrosis, independently from treatment duration.
Conclusions:
Our results showed unexpected worsening of left ventricular function when measured through GLS after HCV treatment response induced by DAAs including sofosbuvir. Although this result is not proven to be clinically significant, the safety profile of sofosbuvir-based regimens needs to be studied further.
More Related Videos
07:39Longitudinal Follow-Up of Urinary Tract Infections and Their Treatment in Mice using Bioluminescence Imaging
Published on: June 14, 2021
11:04Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism
Published on: September 1, 2014
Related Concept Videos
Longitudinal Research
Global Climate Change
Longitudinal Studies
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Dosage Regimen: Individualization
Exponential Functions with Base e